SD

Sheetal Devang Parekh

Active Director Director DIN 10530387
DIN 10530387 First appointment Mar 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sheetal Devang Parekh

Data last updated:

Sheetal Devang Parekh is a Director at Cd India Orphan Drugs Private Limited (since 2024). The company operates in Healthcare.

DIN 10530387
Primary Designation Director
Industry Healthcare
First Appointment 01 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Mar 20242024Active

Board colleagues of Sheetal Devang Parekh

NameDINCompanyDesignation
Shilpa Viral Desai10530388Cd India Orphan Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cd India Orphan Drugs Private Limited
Premium access

Shareholding and investment profile for Sheetal Devang Parekh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheetal Devang Parekh

Sheetal Devang Parekh currently holds 1 directorship: Cd India Orphan Drugs Private Limited (Director, since 01 Mar 2024).

Sheetal Devang Parekh was first appointed on 01 Mar 2024 as Director at Cd India Orphan Drugs Private Limited.

The current boards of Sheetal Devang Parekh's companies include Shilpa Viral Desai (Cd India Orphan Drugs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available